MCP
Mirador Capital Partners’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
41,389
+13,189
| +47% | +$375K | 0.19% | 84 |
|
|
2025
Q1 | $832K | Buy |
28,200
+2,569
| +10% | +$75.8K | 0.15% | 104 |
|
|
2024
Q4 | $745K | Sell |
25,631
-4,867
| -16% | -$142K | 0.14% | 107 |
|
|
2024
Q3 | $1.4M | Sell |
30,498
-10,415
| -25% | -$478K | 0.25% | 64 |
|
|
2024
Q2 | $1.67M | Sell |
40,913
-6,160
| -13% | -$252K | 0.31% | 53 |
|
|
2024
Q1 | $1.2M | Sell |
47,073
-5,488
| -10% | -$140K | 0.23% | 71 |
|
|
2023
Q4 | $476K | Buy |
52,561
+36,195
| +221% | +$328K | 0.1% | 122 |
|
|
2023
Q3 | $104K | Sell |
16,366
-53,395
| -77% | -$341K | 0.02% | 179 |
|
|
2023
Q2 | $774K | Buy |
69,761
+7,250
| +12% | +$80.4K | 0.18% | 94 |
|
|
2023
Q1 | $960K | Buy |
62,511
+28,007
| +81% | +$430K | 0.23% | 73 |
|
|
2022
Q4 | $766K | Buy |
34,504
+384
| +1% | +$8.52K | 0.18% | 85 |
|
|
2022
Q3 | $557K | Sell |
34,120
-663
| -2% | -$10.8K | 0.13% | 103 |
|
|
2022
Q2 | $505K | Buy |
34,783
+967
| +3% | +$14K | 0.12% | 120 |
|
|
2022
Q1 | $625K | Buy |
33,816
+3,115
| +10% | +$57.6K | 0.13% | 121 |
|
|
2021
Q4 | $730K | Buy |
30,701
+9,980
| +48% | +$237K | 0.15% | 109 |
|
|
2021
Q3 | $510K | Buy |
+20,721
| New | +$510K | 0.12% | 133 |
|